Literature DB >> 23271457

The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.

C Jacobsen1, W Zemann, J A Obwegeser, K W Grätz, P Metzler.   

Abstract

INTRODUCTION: The osteopathology of the jaws associated with bone resorption inhibitors is a current topic that engages a variety of clinical specialists. This has increased after the approval of denosumab for treatment of osteoporosis and skeletal-related events in patients with solid malignancy. Early after the first publications, there is a possible connection between phosphorous necrosis of the jaws, a dreadful industrial disease mentioned, and bisphosphonate-induced pathology. The nineteenth century was the prime time for phosphorus necrosis of match factory workers.
RESULTS: This occurrence provides an interesting insight into the medical and surgical profession in the nineteenth century. There are striking parallels and repetition of current and old ideas in the approach to this "new disease." There are similar examples in case descriptions when compared with today's patients of bisphosphonate-related osteonecrosis of the jaws (BRONJ). DISCUSSION: Phosphorus necrosis was first described in Austria. Soon after this, surgeons in German-speaking countries including well-known clinicians Wegner (1872) and von Schulthess-Rechberg (1879) pioneered the analysis, preventative measures, and treatment of this disease. The tendency at this time was to approach BRONJ as a "special kind of osteomyelitis" in pretreated and metabolically different bone. Not only the treatment strategy to wait until sequestrum formation with subsequent removal and preventative measures but also the idea of focusing on the periosteum as the triggering anatomical structure may have been adopted from specialists in the nineteenth century. Therefore, phosphorous necrosis of the jaw is an excellent example of "learning from the past."

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271457     DOI: 10.1007/s10006-012-0376-z

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  21 in total

1.  Bis-phossy jaw, phossy jaw, and the 21st century: bisphosphonate-associated complications of the jaws.

Authors:  John W Hellstein; Cindy L Marek
Journal:  J Oral Maxillofac Surg       Date:  2004-12       Impact factor: 1.895

2.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

3.  Matchmakers' "phossy jaw" eradicated.

Authors:  M L Myers; J D McGlothlin
Journal:  Am Ind Hyg Assoc J       Date:  1996-04

4.  A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw.

Authors:  H Mawardi; G Giro; M Kajiya; K Ohta; S Almazrooa; E Alshwaimi; S-B Woo; I Nishimura; T Kawai
Journal:  J Dent Res       Date:  2011-09-15       Impact factor: 6.116

5.  Extraction socket healing in rats treated with bisphosphonate: animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients.

Authors:  Mehmet Ali-Erdem; Abdulkadir Burak-Cankaya; Sabri Cemil-Isler; Sabit Demircan; Merva Soluk; Cetin Kasapoglu; Cuneyt Korhan-Oral
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2011-11-01

6.  Preventive protocol for tooth extractions in patients treated with zoledronate: a case series.

Authors:  Sebastastiano Ferlito; Sergio Puzzo; Chiara Liardo
Journal:  J Oral Maxillofac Surg       Date:  2011-04-02       Impact factor: 1.895

7.  Osteopathology induced by bisphosphonates and dental implants: clinical observations.

Authors:  Christine Jacobsen; Philipp Metzler; Matthias Rössle; Joachim Obwegeser; Wolfgang Zemann; Klaus-Wilhelm Grätz
Journal:  Clin Oral Investig       Date:  2012-03-15       Impact factor: 3.573

8.  Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.

Authors:  Stefano Fedele; Stephen R Porter; Francesco D'Aiuto; Suad Aljohani; Paolo Vescovi; Maddalena Manfredi; Paolo G Arduino; Roberto Broccoletti; Anna Musciotto; Olga Di Fede; Tony S Lazarovici; Giuseppina Campisi; Naom Yarom
Journal:  Am J Med       Date:  2010-09-28       Impact factor: 4.965

9.  Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?

Authors:  Philippe Lesclous; Semaan Abi Najm; Jean-Pierre Carrel; Brigitte Baroukh; Tommaso Lombardi; Jean-Pierre Willi; René Rizzoli; Jean-Louis Saffar; Jacky Samson
Journal:  Bone       Date:  2009-07-22       Impact factor: 4.398

10.  Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.

Authors:  Stephen T Sonis; Brynmor A Watkins; Gregory D Lyng; Mark A Lerman; Kenneth C Anderson
Journal:  Oral Oncol       Date:  2008-08-19       Impact factor: 5.337

View more
  4 in total

Review 1.  Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary.

Authors:  A M Hinson; C W Smith; E R Siegel; B C Stack
Journal:  Int J Dent       Date:  2014-06-24

2.  Bisphosphonate-related osteonecrosis of the jaw in metastatic breast cancer patients: a review of 25 cases.

Authors:  Hong-Joon Kim; Tae-Jun Park; Kang-Min Ahn
Journal:  Maxillofac Plast Reconstr Surg       Date:  2016-02-01

Review 3.  Review and update on drugs related to the development of osteonecrosis of the jaw.

Authors:  A Eguia; L Bagán-Debón; F Cardona
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01

Review 4.  Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.

Authors:  L Lorusso; L Pieruzzi; M Gabriele; M Nisi; D Viola; E Molinaro; V Bottici; R Elisei; L Agate
Journal:  J Endocrinol Invest       Date:  2021-07-21       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.